Articles

Page 33 of 94

CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization

Authors: D Katinger, S Jeffs, F Altmann, A Cope, P McKay, N Almond, E Sandström, B Hejdeman, G Biberfeld, C Nilsson, D Hallengärd, B Wahren, T Lehner, M Singh, DJ Lewis, C Lacey…

Citation: Retrovirology 2012 9(Suppl 2):P351

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Purification of chemically fixed HIV-1 spikes for oriented display on nanoparticles

Authors: MB Zwick and D Leaman

Citation: Retrovirology 2012 9(Suppl 2):P347

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Native envelope-based immunogens derived from critical timepoints in the development of breadth elicit rapid neutralizing antibodies in rabbits

Authors: DC Malherbe, AJ Hessell, ND Sather, B Guo, S Pandey, F Pissani, H Robins, S Kalams, L Stamatatos and NL Haigwood

Citation: Retrovirology 2012 9(Suppl 2):P345

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Rational modification of an HIV-1 gp120 results in enhanced neutralization breadth when used as a DNA prime

Authors: A Wallace, MJ Duenas-Decamp, M Vaine, PJ Peters, S Wang, PR Clapham and S Lu

Citation: Retrovirology 2012 9(Suppl 2):P343

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Different biological activity of CD154-SIVgp41 fusion protein vaccine component in naïve or pre-immune individuals

Authors: LM Smith, LM Parodi, VL Hodora and LD Giavedoni

Citation: Retrovirology 2012 9(Suppl 2):P339

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen

Authors: K Banerjee, Y Cu, Y Sun, K Hartog, A Dey, L Brito, A Verma, A Nandi, P Sarkar, NM Valiante, AJ Geall, SW Barnett and GR Otten

Citation: Retrovirology 2012 9(Suppl 2):P312

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Development of replication-competent adenovirus based vaccine vectors

Authors: P Abbink, LF Maxfield and DH Barouch

Citation: Retrovirology 2012 9(Suppl 2):P310

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Immunisation with the membrane proximal external region of gp41 of HIV-1 grafted into the transmembrane envelope protein of a gammaretrovirus

Authors: N Strasz, V Morozov, J Kreutzberger, M Lau and J Denner

Citation: Retrovirology 2012 9(Suppl 2):P308

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Control of HIV replication by a novel constitutively active ‘super-PRR’

Authors: S Gupta, J Termini and G Stone

Citation: Retrovirology 2012 9(Suppl 2):P306

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
A high-dimensional immune monitoring model of HIV-1-specific CD8 T cell responses accurately identifies subjects achieving spontaneous viral control

Authors: ZM Ndhlovu, L Chibnik, J Proudfoot, S Vine, A McMullen, K Cesa, F Porichis, D Alvino, A Piechocka-Trocha, P De Jager, BD Walker and D Kaufmann

Citation: Retrovirology 2012 9(Suppl 2):P280

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial

Authors: P Tebas, L Ramirez, MP Morrow, J Yan, D Shah, J Lee, DB Weiner, J Boyer, M Bagarazzi and NY Sardesai

Citation: Retrovirology 2012 9(Suppl 2):P276

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
HIV-specific cytolytic CD4 T-cell responses effectively control HIV infection in macrophages

Authors: DZ Soghoian, M Flanders, K Sierra-Davidson, S Ranasinghe, S Cutler, I Davis, M Lindqvist, K Lane, B Kuhl, G Kranias, A Piechocka-Trocha, H Jessen, BD Walker and H Streeck

Citation: Retrovirology 2012 9(Suppl 2):P274

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Longitudinal assessment of HIV-1-specific T-cell responses generated during acute subtype C HIV-1 infection and associations with viral set point

Authors: M Radebe, Z Ndhlovu, M Mokgoro, L Maphumulo, M Jaggernath, F Chonco, T Ndung'u and BD Walker

Citation: Retrovirology 2012 9(Suppl 2):P272

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Different abilities of CTL specific for two HLA-A*24:02-restricted overlapping optimal epitopes to select same HIV-1 escape mutant virus

Authors: X Sun, M Fujiwara, N Kuse, S Oka and M Takiguchi

Citation: Retrovirology 2012 9(Suppl 2):P268

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Update on policy change proposal to end Institutional Biosafety Committee (IBC) review of rDNA vaccine clinical trials

Authors: ME Enama, N Jones, BS Graham and HC Lane

Citation: Retrovirology 2012 9(Suppl 2):P241

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Training trial staff in the use of a mixed method assessment of understanding tool in HIV vaccine trials

Authors: J Mbogua, T Mebrahtu, G Lindegger, W Sabrina, O Anzala, G Mutua, J Mpendo, E Karita and S Singh

Citation: Retrovirology 2012 9(Suppl 2):P237

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Willingness to participate in HIV vaccine efficacy trials in a population of fishing communities, Uganda

Authors: A Nanvubya, J Mpendo, A Ssetaala, W Kidega, S Sigirenda, L Nielsen and N Kiwanuka

Citation: Retrovirology 2012 9(Suppl 2):P235

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Biodistribution of neutralizing monoclonal antibodies IgG1 b12 and LALA in mucosal and lymphatic tissues of rhesus macaques

Authors: AJ Hessell, E Epson, B Moldt, E Rakasz, S Pandey, WF Sutton, Z Brower, VM Hirsch, DR Burton and NL Haigwood

Citation: Retrovirology 2012 9(Suppl 2):P204

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Human intestinal beta defensins inhibit viral replication and are diminished in chronic untreated HIV infection

Authors: B Corleis, WG Gostic, JA Johnson and DS Kwon

Citation: Retrovirology 2012 9(Suppl 2):P202

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
γδ T-cells in HIV infection

Authors: NG Holt, J Johnson, S Wilton, E Byrne, A Piechocka-Trocha, BD Walker and D Kwon

Citation: Retrovirology 2012 9(Suppl 2):P200

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Semen modulates the differentiation of monocyte-derived dendritic cells towards a tolerogenic profile

Authors: F Remes Lenicov, C Rodríguez Rodrigues, C Jancic, J Sabatté, M Cabrini, M Donalson, R Pasqualini Jr, J Geffner and A Ceballos

Citation: Retrovirology 2012 9(Suppl 2):P199

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
TLR7/9 antagonist reduces HIV-1-induced immune activation

Authors: J Chang, RJ Lindsay, EH Doyle, V Vrbanac, EN Seung, T Dudek, RJ Bosch, M Precopio, E Kandimalla, A Tager and M Altfeld

Citation: Retrovirology 2012 9(Suppl 2):P172

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
KIR-HLA footprints and NK cell-mediated recognition of HIV-1

Authors: CF Thobakgale, J Carlson, J Wright, N van Teijlingen, M Jaggernath, P Goulder, BD Walker, M Carrington, D Heckerman, M Altfeld and T Ndung'u

Citation: Retrovirology 2012 9(Suppl 2):P170

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Association of interleukin-10 promoter genetic variants with T-cell and B-cell activation in HIV-1 infection

Authors: D Naicker, B Julg, C McClurg, M Ghebremichael, F Porichis, J Zupkosky, M Jaggernath, M Mokgoro, P Goulder, B Walker, D Kaufmann and T Ndung'u

Citation: Retrovirology 2012 9(Suppl 2):P168

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
The prognostic and diagnostic use of microRNA expression in chronic HIV infection

Authors: L Zhu, C Qiu, C Ma, X Zhang and J Xu

Citation: Retrovirology 2012 9(Suppl 2):P166

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Sequence based typing of HLA-A and B Exons-2 and -3 in a HIV-positive native community with limited HLA diversity from the North of Argentina

Authors: DA Dilernia, D Mónaco, R Coloccini, M Pando, M Quipildor, A Di Paolo, E Hunter and H Salomon

Citation: Retrovirology 2012 9(Suppl 2):P164

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials

Authors: C Morgan, X Jin, X Yu, S De Rosa, J Kublin, B Metch, M Keefer and H NIAID

Citation: Retrovirology 2012 9(Suppl 2):P133

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
HIV vaccine trial safety and retention among 18-20 year olds in the HVTN 503/Phambili study support the inclusion of adolescents in future trials

Authors: JE Volk, NA Hessol, GE Gray, JG Kublin, G Churchyard, K Mlisana, M Nchabeleng, SP Buchbinder and L Bekker

Citation: Retrovirology 2012 9(Suppl 2):P131

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Developing Community Advisory Board guidelines for AIDS vaccine trials in China

Authors: JA Kaufman, C Liu and A Menezes

Citation: Retrovirology 2012 9(Suppl 2):P129

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
A dose-escalation clinical trial to evaluate the safety and immunogenicity of a replication-defective HIV-1 vaccine-HIVAX

Authors: F Tung, J Tung and M Fischl

Citation: Retrovirology 2012 9(Suppl 2):P127

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
HIV-1 neutralizing antibodies display dual specificity for the primary and coreceptor binding sites and preferential recognition of fully-cleaved Env

Authors: Y Li, S O’Dell, R Wilson, X Wu, SD Schmidt, C Hogerkorp, MK Louder, N Longo, C Poulsen, J Guenaga, B Chakrabarti, N Doria-Rose, M Roederer, M Connors, JR Mascola and RT Wyatt

Citation: Retrovirology 2012 9(Suppl 2):P99

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus

Authors: LM Mayr, RL Powell, JN Ngai, A Nádas and PN Nyambi

Citation: Retrovirology 2012 9(Suppl 2):P72

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Crystal structure analysis of anti-V2 mAb 2158 suggests a conformational epitope involving an N-linked glycan

Authors: B Spurrier, R Pan, J Sampson, C Williams, M Gorny, S Zolla-Pazner and X Kong

Citation: Retrovirology 2012 9(Suppl 2):P70

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Characteristics of HIV-1 gp120 molecules that bind ancestor, intermediate and mature forms of VRC01-like antibodies

Authors: M Joyce, B Zhang, T Zhou, S Moquin, X Wu, M Louder, Z Zhang, I Georgiev, J Zhu, L Shapiro, JR Mascola, GJ Nabel and PD Kwong

Citation: Retrovirology 2012 9(Suppl 2):P68

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Comparison of the neutralization sensitivity of South African and Indian HIV-1 subtype C viruses to South African plasma antibodies

Authors: T Hermanus, N Mkhize, P Moore, M Nonyane, J Battacharya, SA Karim and L Morris

Citation: Retrovirology 2012 9(Suppl 2):P66

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Construction and characterization of neutralizing antibody fragments for efficient access to V3 epitope

Authors: Y Maruta

Citation: Retrovirology 2012 9(Suppl 2):P64

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120

Authors: JM Kovacs, JP Nkolola, H Peng, A Cheung, J Perry, CA Miller, MS Seaman, D Barouch and B Chen

Citation: Retrovirology 2012 9(Suppl 2):O62

Content type: Oral presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Beneficial HLA-mediated viral polymorphisms on the transmitted virus additively influence disease progression in HIV-1, subtype C infection

Authors: RS Ntale, DR Chopera, NK Ngandu, M Abrahams, A Debra, M Mlotswa, L Werner, Z Woodman, K Mlisana, S Abdool Karim, CM Gray and C Williamson

Citation: Retrovirology 2012 9(Suppl 2):O60

Content type: Oral presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
A deeper view of transmitted/founder viruses using 454 whole genome deep sequencing

Authors: DC Tully, KA Power, H Bedard, CL Boutwell, P Charlebois, EM Ryan, NJ Lennon, M Altfeld, MR Henn and TM Allen

Citation: Retrovirology 2012 9(Suppl 2):O58

Content type: Oral presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles

Authors: P Goepfert, M Elizaga, D Montefiori, J Hural, S DeRosa, G Tomaras, K Seaton, A Sato, L Ouedraogo, Y Donastorg, M Cardinali, J Lama, L Baden, M Keefer, J McElrath, S Kalams…

Citation: Retrovirology 2012 9(Suppl 2):O56

Content type: Oral presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Maturation of protective immunity induced by SIVΔnef correlates with differential expression of transcription factors in SIV-specific CD8+ T cells

Authors: JM Billingsley, PA Rajakumar, NC Salisch, YV Kuzmichev, HS Hong, MA Connole, RK Reeves, H Kang, W Li and RP Johnson

Citation: Retrovirology 2012 9(Suppl 2):P33

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Optimizing delivery of HIV-1 conserved region-derived immunogen for induction of T and B cell responses in rhesus macaques

Authors: M Rosario, G Koopman, A Mbewe-Mvula, ML Knudsen, ED Quakkelaar, N Borthwick, R Wagner, DA Price, P Liljestrom, CJ Melief, JW Drijfhout, S Colloca, A Nicosia and T Hanke

Citation: Retrovirology 2012 9(Suppl 2):P31

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
SIVconsv DNA prime - TLR7/IFNα adjuvanted long peptide boost induces potent CD4+ Ab responses and protects against high dose intrarectal SIV challenge

Authors: G Koopman, N Beenhakker, I Nieuwenhuis, G Doxiadis, P Mooij, JW Drijfhout, J Koestler, T Hanke, RE Bontrop, R Wagner, WM Bogers and CJ Melief

Citation: Retrovirology 2012 9(Suppl 2):P29

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Induction of HIV-1 Gag-specific memory T cells in Chacma baboons by MVA prime and VLP boost vaccine regimen

Authors: V Singh, G Chege, E Shephard and A Williamson

Citation: Retrovirology 2012 9(Suppl 2):P27

Content type: Poster presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
An assessment of Good Participatory Practice Guidelines at HIV prevention research clinical centers in Eastern and Southern Africa

Authors: BP Ngongo, S Hannah, J Mbogua, M Seyoum, M Warren, E Baas and F Priddy

Citation: Retrovirology 2012 9(Suppl 2):O25

Content type: Oral presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Inflammation in the male genital tract: implications for HIV acquisition and transmission

Authors: AJ Olivier, L Roberts, D Coetzee, A Williamson, JS Passmore and WA Burgers

Citation: Retrovirology 2012 9(Suppl 2):O23

Content type: Oral presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Immune complexes can dampen inflammatory signaling at the mucosal surface during protective SIV vaccination

Authors: AJ Smith, SW Wietgrefe, CS Reilly, PJ Southern, L Duan, KE Perkey, L Shang, R Johnson and AT Haase

Citation: Retrovirology 2012 9(Suppl 2):O19

Content type: Oral presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
MAb PGT121 protects against mucosal SHIV challenge in macaques at concentrations corresponding to its highly potent in vitro neutralization capacity

Authors: B Moldt, EG Rakasz, N Schultz, P Chan-Hui, K Swiderek, DI Watkins, DR Burton and P Poignard

Citation: Retrovirology 2012 9(Suppl 2):O5

Content type: Oral presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Immune control of an SIV challenge by a heterolgous and direct mucosal vaccination regimen in rhesus monkeys

Authors: C Sun, Z Chen, X Tang, Y Zhang, L Feng, Y Du, L Xiao, L Liu, W Zhu, L Chen and L Zhang

Citation: Retrovirology 2012 9(Suppl 2):O3

Content type: Oral presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF
Significant protection from infection and AIDS progression after gastrointestinal and oral vaccinations, respectively, with a SIV DNA/rMVA vaccine

Authors: A Aldovini, M Manrique, A Cobo-Molinos, P Kozlowski and A Carvlle

Citation: Retrovirology 2012 9(Suppl 2):O1

Content type: Oral presentation Published on: 13 September 2012

This article is part of a Supplement: Volume 9 Supplement 2
- View Full Text
- View PDF

How was your experience today?

Rating Please select one rating

Awful

Bad

Good

Great

Thank you for your feedback.

Tell us why (opens in a new tab)

Articles

Follow

Annual Journal Metrics

Retrovirology

Contact us